Bixiye
QP10-21 Commercial Pharmacy Benefit Exclusion for Emtricitabine-Tenofovir Disoproxil Fumarate Tablet 100-150 mg, 133-200 mg, and 167-250 mg
Taariikhda uu dhaqangalayo Barnaamijka: 10, Feb 2021
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2211 - 2220 ee natiijooyinka 3167
Bixiye
QP12-21 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective April 1, 2021
Taariikhda uu dhaqangalayo Barnaamijka: 10, Feb 2021
Bixiye
QP14-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Enspryng™(satralizumab-mwge) PAQL
Taariikhda uu dhaqangalayo Barnaamijka: 10, Feb 2021
Bixiye
QP13-21 Commercial and MHCP Pharmacy Benefit Exclusion for Cabenuva
Taariikhda uu dhaqangalayo Barnaamijka: 10, Feb 2021
Bixiye
QP9-21 New Request Form for Medical Policy Coverage Exception Requests for Commercial Members
Taariikhda uu dhaqangalayo Barnaamijka: 10, Feb 2021
Bixiye
QP16-21 Overpayment Refund/Recoupment Notification Process for Minnesota Health Care Programs
Taariikhda uu dhaqangalayo Barnaamijka: 10, Feb 2021
Bixiye
QP15-21 Provider Fee Schedule Request
Taariikhda uu dhaqangalayo Barnaamijka: 10, Feb 2021
Bixiye
P6-21 New Medical Policy IV-168: Hysterectomy Surgery for Non-Malignant Conditions
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2021
Bixiye
P93R1-20 Update: Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2021
Bixiye
P9-21 New Claim Edits for Professional Lab Claims Missing Required Data
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2021